[Adverse effect of sclerosants on the liver, kidney and lung].
Sakai
M
M
1st Department of Surgery, St. Marianna University School of Medicine.
Hagiwara
M
M
Okano
T
T
Nakano
S
S
Nagaoka
S
S
Ikari
J
J
Kubota
S
S
Watanabe
H
H
D004932:Esophageal and Gastric Varices / Q000628:therapy; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology* / Q000517:prevention & control; D008107:Liver Diseases / Q000209:etiology* / Q000517:prevention & control; D008875:Middle Aged; D010996:Pleural Effusion / Q000209:etiology* / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000209:etiology* / Q000517:prevention & control; D012306:Risk; D012597:Sclerosing Solutions / Q000009:adverse effects*
D012597:Sclerosing Solutions